• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchVaxxinity
    Picture of Vaxxinity logo

    VAXX — Vaxxinity News Story

    $0.000.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    • Market Cap
      $0.01m
    • Enterprise Value
      -$15.21m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • VAXX Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    VAXX Dividends
    All News

    NASDAQ RESUMED AT 10:04 AM

    Picture of Vaxxinity logoVaxxinity
    03/05/2022 15:04
    NASDAQ RESUMED  VAXX.O  AT 10:04 AM
    

    Recent news on Vaxxinity

    See all news
    • U.S. STOCKS ON THE MOVE-EV stocks, Salesforce, Verizon

      22/04/2024 12:52
    • Brief: Vaxxinity Announces Intention To Voluntarily Delist And Deregister Its Class A Common Stock

      19/04/2024 23:18
    • Brief: Vaxxinity Announces Intention To Voluntarily Delist And Deregister Its Class A Common Stock

      19/04/2024 21:11
    • Brief: Vaxxinity Q4 Net Income USD -11.392 Million

      27/03/2024 20:41
    • Vaxxinity Inc expected to post a loss of 10 cents a share - Earnings Preview

      22/03/2024 11:17

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.